Correlation Between Vitrolife and CellaVision

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vitrolife and CellaVision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and CellaVision into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vitrolife AB and CellaVision AB, you can compare the effects of market volatilities on Vitrolife and CellaVision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of CellaVision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and CellaVision.

Diversification Opportunities for Vitrolife and CellaVision

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vitrolife and CellaVision is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and CellaVision AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CellaVision AB and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with CellaVision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CellaVision AB has no effect on the direction of Vitrolife i.e., Vitrolife and CellaVision go up and down completely randomly.

Pair Corralation between Vitrolife and CellaVision

Assuming the 90 days trading horizon Vitrolife AB is expected to under-perform the CellaVision. But the stock apears to be less risky and, when comparing its historical volatility, Vitrolife AB is 1.09 times less risky than CellaVision. The stock trades about -0.09 of its potential returns per unit of risk. The CellaVision AB is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  22,100  in CellaVision AB on October 23, 2024 and sell it today you would earn a total of  650.00  from holding CellaVision AB or generate 2.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Vitrolife AB  vs.  CellaVision AB

 Performance 
       Timeline  
Vitrolife AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vitrolife AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
CellaVision AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CellaVision AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Vitrolife and CellaVision Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vitrolife and CellaVision

The main advantage of trading using opposite Vitrolife and CellaVision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, CellaVision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CellaVision will offset losses from the drop in CellaVision's long position.
The idea behind Vitrolife AB and CellaVision AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamental Analysis
View fundamental data based on most recent published financial statements
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities